ANG Lifesciences India Limited (ANG.BO)

INR 28.9

(-2.0%)

Market Cap (In INR)

377.38 Million

Revenue (In INR)

1.46 Billion

Net Income (In INR)

-101.43 Million

Avg. Volume

14.25 Thousand

Currency
INR
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
26.55-89.9
PE
-2.67
EPS
-10.81
Beta Value
1.7249665
ISIN
INE236W01016
CUSIP
-
CIK
-
Shares
13058300.0
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Rajesh Gupta
Employee Count
-
Website
http://www.anglifesciences.com
Ipo Date
Details
ANG Lifesciences India Ltd. engages in the manufacture and marketing of finished pharmaceutical formulations in a form of sterile dry powder for injection vials. Its products include sterile dry powder vials for antibiotics, anti ulcerant, glucocorticoid, and anti-inflammatory, anti-malaria, and anesthetics. The company was founded by Rajesh Gupta on June 14, 2006 and is headquartered in Amritsar, India.